Pharmaceutical Preparations
20 companies analysed from SEC EDGAR filings. Compare valuations, profitability, and risk across the sector.
Companies
20
Total mkt cap
—
Sector P/E (ETF)
—
Avg gross margin
20824.2%
Strong / Positive
5
Caution / At Risk
3
Metrics comparison
| Company | Mkt Cap↓ | P/E (vs sector) | Gross Margin | Net Margin | D/E Ratio | Risks |
|---|---|---|---|---|---|---|
| INVAINNOVIVA, INC. | — | — | 141.6% | 124.8% | 0.64 | 1 |
| ABBVAbbVie Inc. | — | — | 19.7% | 6.9% | — | 1 |
| RCUSArcus Biosciences, Inc. | — | — | — | -142.9% | 0.16 | 3 |
| ARDXARDELYX, INC. | — | — | 179.6% | -2362.8% | 1.21 | 4 |
| ASRTASSERTIO HOLDINGS, INC. | — | — | — | -25.6% | 0.41 | 4 |
| XNCRXencor, Inc | — | — | — | -73.2% | 0.12 | 3 |
| PTCTPTC Therapeutics, Inc. | — | — | — | 257.9% | — | 2 |
| PAHCPhibro Animal Health Corporation | — | — | 48.0% | 5.8% | 1.09 | 1 |
| PCRXPACIRA BIOSCIENCES, INC. | — | — | — | 1.3% | 0.54 | — |
| HROWHarrow, Inc. | — | — | 75.1% | -1.9% | 4.77 | 2 |
| LLYELI LILLY AND COMPANY | — | — | — | 31.7% | 1.11 | — |
| REGNREGENERON PHARMACEUTICALS, INC. | — | — | — | 76.7% | 0.06 | 1 |
| MRKMerck & Co., Inc. | — | — | — | 28.1% | 0.89 | — |
| ABTABBOTT LABORATORIES | — | — | 9.9% | 14.7% | 0.25 | 1 |
| BMYBristol-Myers Squibb Company | — | — | 63.8% | 14.6% | 2.43 | 1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | — | — | — | 158.8% | — | 1 |
| ZTSZoetis Inc. | — | — | — | 28.2% | 2.71 | 1 |
| JNJJohnson & Johnson | — | — | 67.9% | 28.5% | 0.51 | 1 |
| PRGOPerrigo Company plc | — | — | 186812.5% | -178175.0% | 0.28 | 2 |
| NRIXNURIX THERAPEUTICS, INC. | — | — | — | -343.5% | — | 3 |